Can we treat patients with prior radiotherapy and severe urinary incontinence post prostatectomy with Advance XP male sling? A comparative study with an one year follow up.

Lebani B1, Baungratz M1, Silva A1, Lima H2, Silveira E2, Almeida F2, Zequi S1

Research Type

Clinical

Abstract Category

Male Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction

Abstract 229
Male LUTS Prostate and more
Scientific Podium Short Oral Session 26
Friday 9th October 2026
11:00 - 11:07
Parallel Hall 2
Stress Urinary Incontinence Surgery Incontinence
1. AC CAMARGO CANCER CENTER, 2. Paulista School of Medicine
Presenter
Links

Abstract

Hypothesis / aims of study
Urinary incontinence is a hostile complication following radical prostatectomy in patients with prostate cancer. The AUS achieves higher continence rates than male slings; however, its revision rates are not insignificant. 
The aim of this study was to investigate whether the Advance XP sling could be an effective treatment option to improve quality of life in patients with severe PPI, including those who had undergone prior radiotherapy (RT), at 12 months follow up.
Additionally, we assessed clinical and urodynamic features as predictors of success or failure among all patients and between groups.
Study design, materials and methods
Thi is a prospective study assessing the satisfaction, social continence and urodynamic predictors of failure for patients who had undergone to male sling to treat PPI.
All patients underwent a standard procedure involving the implantation of the male sling (Boston Scientific AdVance™ XP Male Sling System). 
Baseline symptoms such as urgency and nocturia were also recorded. All patients underwent urodynamic studies prior to sling implantation, following the best practices recommended by the International Continence Society (12).
The parameters assessed included cystometric capacity (ml), presence and amplitude of detrusor overactivity (cmH2O), bladder sensivity and compliance (ml/cmH2O), abdominal leak point pressure – ALPP (cmH2O) and leakage volume. Pressure-flow studies were also perfomed in all patients.
Postoperatively, patients were evaluated regarding their satisfaction with the procedure [Patient Global Impression of Improvement (PGI-I) - ranging from 0% – not at all satisfied – to 100% - totally satisfied], improvement in quality of life (QoL), as well as changes in PPD usage, severity of nocturia, and urgency. 
The correlation between patient satisfaction after the procedure and all clinical and urodynamic parameters were analyzed. Patients with prior Radiotherapy (RT) were assessed separately after que initial analysis, to determine whether the outcomes were inferior compared to those patients without RT, according to previous evidence
Results
Fifty-eight patients with severe post prostatectomy urinary incontinence underwent Advance XP male sling. 
The two groups (Radiotherapy vs without Radiotherapy) were similar, although significant differences were observed between them regarding ALPP and cystometric capacity (CC). The group that had undergone RT presented lower ALPP and lower CC.
Overall satisfaction at 12 months follow-up in patients with severe urinary incontinence was high (mean 86,717.1 %). There was no difference between groups regarding satisfaction [RT group 82.3% vs Non-RT group 90%, [p=0.146 (-4.06,19.4), Mann Whitney test].
It was not found any difference after surgery in PPD used, post operative SCT or urgency between patients with or without RT, although patients with RT had lower ALPP preoperatively (p<0.05).
A bladder capacity (CC < 300 ml) emerged as the main feature which predicts poorer outcomes, regarding higher rates of detrusor overactivity (p=0.02), satisfaction (p=0.02), early leakage volume (p=0.02) and increased nocturia (p=0.02), presenting statistical differences
Interpretation of results
We believe our results highlight and urge new further large-scale and prospective studies to assess the efficacy of the Advance XP in patients with severe urinary incontinence. This is particularly important especially due to the higher costs of the artificial urinary sphincter in developing countries, where AUS is not easily available. We attribute our favorable results to surgical technique, especially due to the urethral mobilization through the release of the central tendon of the perineum, a critical and essential step during the surgery to achieve continence postoperatively.
Concluding message
Advance XP sling represents a viable option to treat patients with severe urinary incontinence, reaching high satisfaction rates and social continence. Although prior radiotherapy decreases social continence outcomes, overall patient satisfaction remains acceptable.
Figure 1
References
  1. Abrams P. et al. Outcomes of a Noninferiority Randomised Controlled Trial of Surgery for Men With Urodynamic Stress Incontinence After Prostate Surgery (MASTER). European Urology. 2021;79(6):812-823. doi:10.1016/j.eururo.2021.01.024.
  2. 14. Chen HC et al. Male sling versus artificial urinary sphincter for the treatment of incontinence after prostate surgery: a systematic review with meta-analysis. Transl Androl Urol. 2024 Aug 31;13(8):1416-1424. doi: 10.21037/tau-24-107. Epub 2024 Aug 23
  3. 15. Favero LD et al. Long-term Functional Outcomes and Patient Satisfaction After AdVance and AdVanceXP Male Sling Surgery. Eur Urol Focus. 2022 Sep;8(5):1408-1414. doi: 10.1016/j.euf.2022.01.017. Epub 2022 Feb 10
Disclosures
Funding No disclosures Clinical Trial No Subjects Human Ethics Committee The study was registered and approved by our Clinical Ethical committee (CAAE: 84277724.0.0000.5432) Helsinki Yes Informed Consent Yes AI Not at all
06/06/2026 09:39:49